Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Sinus Bradycardia Devices Market by Type (Pacemaker, Implantable Cardioverter Defibrillator), By Application (Sinus Cardiac arrest, Sinus Atrial Block, Sinus Node Syndrome, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Sinus Bradycardia Devices Market by Type (Pacemaker, Implantable Cardioverter Defibrillator), By Application (Sinus Cardiac arrest, Sinus Atrial Block, Sinus Node Syndrome, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 212513 3300 Medical Devices & Consumables 377 242 Pages 4.9 (33)
                                          

The global sinus bradycardia devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of sinus bradycardia, rising awareness about the benefits of sinus bradycardia devices, and technological advancements in the field. The global sinus bradycardia devices market is segmented on the basis of type into pacemaker and implantable cardioverter defibrillator (ICD). The pacemaker segment accounted for a share of over 50% in 2017 and is expected to maintain its dominance throughout the forecast period. The ICD segment accounted for a share of over 40% in 2017 and is expected to witness significant growth during the forecast period owing to its ability to provide protection against sudden cardiac death (SCD) by delivering an electric shock when needed. On the basis of application, this market can be divided into sinus cardiac arrest, sinus atrial block, and sinus node syndrome. Sinus cardiac arrest accounted for a share over 60% in 2017 owing to its high incidence rate among patients with heart disease or other underlying conditions that cause abnormal heart rhythms or arrhythmias such as Wolff-Parkinson-White syndrome (WPW). Sinus atrial block was estimated at around 10% in 2017 due to its low incidence rate among patients with heart disease or other underlying conditions that cause abnormal heart rhythms or arrhythmias such as WPW.

Some Of The Growth Factors Of This Market:

  1. Increasing prevalence of heart diseases and increasing awareness about the benefits of Sinus Bradycardia Devices are some factors that are driving the growth of this market.
  2. Increasing number of hospitals and clinics in emerging economies such as China, India, Brazil, and Mexico is also driving the growth of this market.
  3. The high cost associated with Sinus Bradycardia Devices is a major factor restraining the growth of this market.
  4. Lack of skilled professionals in emerging economies such as China, India, Brazil, and Mexico is also restraining the growth.

Industry Growth Insights published a new data on “Sinus Bradycardia Devices Market”. The research report is titled “Sinus Bradycardia Devices Market research by Types (Pacemaker, Implantable Cardioverter Defibrillator), By Applications (Sinus Cardiac arrest, Sinus Atrial Block, Sinus Node Syndrome, Other), By Players/Companies Abbott Laboratories, Biotronik, Boston Scientific, Lepu Medical, Livanova, Medico, Medtronic, Oscor, Osypka Medical, Shree Pacetronix, Cook Medical, Spectranetics, St. Jude Medical, Nihon Kohden, PHILIPS HEALTHCARE, Sorin Group, ZOLL Medical Corporation, Galix Biomedical Instrumentation, Integer Holdings Corporation”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Sinus Bradycardia Devices Market Research Report

By Type

Pacemaker, Implantable Cardioverter Defibrillator

By Application

Sinus Cardiac arrest, Sinus Atrial Block, Sinus Node Syndrome, Other

By Companies

Abbott Laboratories, Biotronik, Boston Scientific, Lepu Medical, Livanova, Medico, Medtronic, Oscor, Osypka Medical, Shree Pacetronix, Cook Medical, Spectranetics, St. Jude Medical, Nihon Kohden, PHILIPS HEALTHCARE, Sorin Group, ZOLL Medical Corporation, Galix Biomedical Instrumentation, Integer Holdings Corporation

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

242

Number of Tables & Figures

170

Customization Available

Yes, the report can be customized as per your need.


Global Sinus Bradycardia Devices Industry Outlook


Global Sinus Bradycardia Devices Market Report Segments:

The global Sinus Bradycardia Devices market is segmented on the basis of:

Types

Pacemaker, Implantable Cardioverter Defibrillator

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Sinus Cardiac arrest, Sinus Atrial Block, Sinus Node Syndrome, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. Biotronik
  3. Boston Scientific
  4. Lepu Medical
  5. Livanova
  6. Medico
  7. Medtronic
  8. Oscor
  9. Osypka Medical
  10. Shree Pacetronix
  11. Cook Medical
  12. Spectranetics
  13. St. Jude Medical
  14. Nihon Kohden
  15. PHILIPS HEALTHCARE
  16. Sorin Group
  17. ZOLL Medical Corporation
  18. Galix Biomedical Instrumentation
  19. Integer Holdings Corporation

Global Sinus Bradycardia Devices Market Overview


Highlights of The Sinus Bradycardia Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Pacemaker
    2. Implantable Cardioverter Defibrillator
  1. By Application:

    1. Sinus Cardiac arrest
    2. Sinus Atrial Block
    3. Sinus Node Syndrome
    4. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Sinus Bradycardia Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Sinus Bradycardia Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A sinus Bradycardia device is a medical device that helps to regulate the heart rate in people with sinus arrhythmia.

Some of the key players operating in the sinus bradycardia devices market are Abbott Laboratories, Biotronik, Boston Scientific, Lepu Medical, Livanova, Medico, Medtronic, Oscor, Osypka Medical, Shree Pacetronix, Cook Medical, Spectranetics, St. Jude Medical, Nihon Kohden, PHILIPS HEALTHCARE, Sorin Group, ZOLL Medical Corporation, Galix Biomedical Instrumentation, Integer Holdings Corporation.

The sinus bradycardia devices market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Sinus Bradycardia Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Sinus Bradycardia Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Sinus Bradycardia Devices Market - Supply Chain
   4.5. Global Sinus Bradycardia Devices Market Forecast
      4.5.1. Sinus Bradycardia Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Sinus Bradycardia Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Sinus Bradycardia Devices Market Absolute $ Opportunity

5. Global Sinus Bradycardia Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Sinus Bradycardia Devices Market Size and Volume Forecast by Type
      5.3.1. Pacemaker
      5.3.2. Implantable Cardioverter Defibrillator
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Sinus Bradycardia Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Sinus Bradycardia Devices Market Size and Volume Forecast by Application
      6.3.1. Sinus Cardiac arrest
      6.3.2. Sinus Atrial Block
      6.3.3. Sinus Node Syndrome
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Sinus Bradycardia Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Sinus Bradycardia Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Sinus Bradycardia Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Sinus Bradycardia Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Sinus Bradycardia Devices Demand Share Forecast, 2019-2026

9. North America Sinus Bradycardia Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Sinus Bradycardia Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Sinus Bradycardia Devices Market Size and Volume Forecast by Application
      9.4.1. Sinus Cardiac arrest
      9.4.2. Sinus Atrial Block
      9.4.3. Sinus Node Syndrome
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Sinus Bradycardia Devices Market Size and Volume Forecast by Type
      9.7.1. Pacemaker
      9.7.2. Implantable Cardioverter Defibrillator
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Sinus Bradycardia Devices Demand Share Forecast, 2019-2026

10. Latin America Sinus Bradycardia Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Sinus Bradycardia Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Sinus Bradycardia Devices Market Size and Volume Forecast by Application
      10.4.1. Sinus Cardiac arrest
      10.4.2. Sinus Atrial Block
      10.4.3. Sinus Node Syndrome
      10.4.4. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Sinus Bradycardia Devices Market Size and Volume Forecast by Type
      10.7.1. Pacemaker
      10.7.2. Implantable Cardioverter Defibrillator
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Sinus Bradycardia Devices Demand Share Forecast, 2019-2026

11. Europe Sinus Bradycardia Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Sinus Bradycardia Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Sinus Bradycardia Devices Market Size and Volume Forecast by Application
      11.4.1. Sinus Cardiac arrest
      11.4.2. Sinus Atrial Block
      11.4.3. Sinus Node Syndrome
      11.4.4. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Sinus Bradycardia Devices Market Size and Volume Forecast by Type
      11.7.1. Pacemaker
      11.7.2. Implantable Cardioverter Defibrillator
   11.8. Basis Point Share (BPS) Analyis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Sinus Bradycardia Devices Demand Share, 2019-2026

12. Asia Pacific Sinus Bradycardia Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Sinus Bradycardia Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Sinus Bradycardia Devices Market Size and Volume Forecast by Application
      12.4.1. Sinus Cardiac arrest
      12.4.2. Sinus Atrial Block
      12.4.3. Sinus Node Syndrome
      12.4.4. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Sinus Bradycardia Devices Market Size and Volume Forecast by Type
      12.7.1. Pacemaker
      12.7.2. Implantable Cardioverter Defibrillator
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Sinus Bradycardia Devices Demand Share, 2019-2026

13. Middle East & Africa Sinus Bradycardia Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Sinus Bradycardia Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Sinus Bradycardia Devices Market Size and Volume Forecast by Application
      13.4.1. Sinus Cardiac arrest
      13.4.2. Sinus Atrial Block
      13.4.3. Sinus Node Syndrome
      13.4.4. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Sinus Bradycardia Devices Market Size and Volume Forecast by Type
      13.7.1. Pacemaker
      13.7.2. Implantable Cardioverter Defibrillator
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Sinus Bradycardia Devices Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Sinus Bradycardia Devices Market: Market Share Analysis
   14.2. Sinus Bradycardia Devices Distributors and Customers
   14.3. Sinus Bradycardia Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott Laboratories
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Biotronik
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Boston Scientific
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Lepu Medical
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Livanova
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Medico
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Medtronic
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Oscor
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Osypka Medical
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Shree Pacetronix
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Cook Medical
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Spectranetics
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. St. Jude Medical
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Nihon Kohden
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. PHILIPS HEALTHCARE
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Sorin Group
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. ZOLL Medical Corporation
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Galix Biomedical Instrumentation
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Integer Holdings Corporation
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us